Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Dapagliflozin in CPAP-naive OSA
NCT06690723Phase 3Completed
- Sponsor
- Universiti Malaysia Sarawak
- Start
- Jun 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in hypertension (HTN), obstructive sleep apnea (OSA), sponsored by Universiti Malaysia Sarawak. Started Jun 2022; status: completed.
02
Drugs
dapagliflozin
03
Conditions
hypertension (HTN)obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT06690723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06690723.